Dr. Ping Li, PhD, MD, MS
Head of Vital Organ Pharmacology Center Metabolic Disease, Cardiovascular Disease, Endocrinology, Hepatobiliary Disease, Women's Health
Dr. Ping Li received his Clinical Medicine MD and MS in pharmacology degrees from the School of Medicine, Zhejiang University before earning his PhD in Cardiovascular Pathophysiology from Peking University Health Science. Dr. Li continued his research at Duke University Medical Center and Harvard Public Health School in several areas of cardiometabolic diseases including skeletal muscle biology, obesity, T2D and liver diseases. In 2010, he joined the National Institutes of Health (NIH) as a Staff Scientist where he further investigated the regulation of metabolism using a broad range of in vitro and in vivo experimental approaches as well as human genetic analysis and large-scale human data mining. Before joining WuXi Biology in July 2026, he worked as a Principal Scientist at Novo Nordisk Research Center China in Beijing where he focused on target discovery and validation for cardiorenal and metabolic diseases.